1-3 of 3
Christopher Patterson, MD
Close
Sort by
Journal Articles

Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia

Steven Treon, MD, PhD, Andrew Branagan, Leukothea Ioakimidis, PhD, Jacob Soumerai, Christopher Patterson, MD, Parveen Wasi, MD, FRCP(C), Christos Emmanouilides, MD, PhD, Stanley R. Frankel, MD, T. Andrew Lister, MD, Pierre Morel, MD, Jeffrey Matous, MD, Stephanie A. Gregory, MD, Eva K. Kimby, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3057.
https://doi.org/10.1182/blood.V112.11.3057.3057
Published: 2008
Journal Articles

Comparative Outcomes Following CP-R, CVP-R and CHOP-R in Patients with Waldenstrom’s Macroglobulinemia.

Leukothea Ioakimidis, PhD, Christopher Patterson, MD, Jacob Soumerai, Robert Manning, Patricia Sheehy, NP, Steven Treon, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2011.
https://doi.org/10.1182/blood.V112.11.2011.2011
Published: 2008
Journal Articles

IgA and IgG Hypogammaglobulinemia Is a Constitutive Feature in Most Waldenstrom’s Macroglobulinemia Patients and May Be Related to Mutations Associated with Common Variable Immunodeficiency Disorder (CVID)

Steven Treon, MD, PhD, Zachary Hunter, Bryan Ciccarelli, Yangsheng Zhou, MD, Christina Hanzis, Robert Manning, Leukothea Ioakimidis, PhD, Lian Xu, Christopher Patterson, MD, Massimo Morra, MD
Journal: Blood
Blood (2008) 112 (11): 3749.
https://doi.org/10.1182/blood.V112.11.3749.3749
Published: 2008